Development of high yield reassortants for influenza type B viruses and analysis of their gene compositions

Vaccine

Volumn 33, Issue 7, 2015, Pages 879-884

  Le, Jianhua ^a   Orff, Edward J ^a   Fulvini, Andrew A ^a   Huang, Liling ^a   Onodera, Shiroh ^a   Pokorny, Barbara A ^a   Malewicz, Andrew ^a   Primakov, Patricia ^a   Bucher, Doris J ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Classical reassortment; High yield reassortants; Influenza B gene composition; Influenza vaccine; Vaccine seed virus

Indexed keywords

INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; VIRUS PROTEIN; VIRUS SIALIDASE;

ARTICLE; GENETIC REASSORTMENT; HEMAGGLUTINATION; INFLUENZA VIRUS B; NONHUMAN; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; VACCINE PRODUCTION; VIRUS GENE; GENETICS; HUMAN; IMMUNOLOGY; INFLUENZA; INFLUENZA B VIRUS;

HUMANS; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; REASSORTANT VIRUSES; VIRAL PROTEINS;

EID: 84921806974     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.12.027     Document Type: Article

References (24)

1. Kilbourne E.D. Future influenza vaccines and the use of genetic recombinants. Bull World Health Organ 1969, 41(3):643-645.
2. Tobita K., Kilbourne E.D. Genetic recombination for antigenic markers of antigenically different strains of influenza B virus. J Virol 1974, 13(2):347-352.
3. Kilbourne E.D. The control of influenza. Influenza 1987, 291-325. Plenum Medical Book Company, New York.
4. Goodeve A.C., Jennings R., Potter C.W. Reassortants of influenza B viruses for use in vaccines: an evaluation. Arch Virol 1985, 83(3-4):169-179.
5. Beare A.S., Sherwood J.E., Callow K.A., Craig J.W. Selection of influenza B virus recombinants and their testing in humans for attenuation and immunogenicity. Infect Immun 1977, 15(2):347-353.
6. Vodeiko G.M., McInnis J., Chizhikov V., Levandowski R.A. Genetic and phenotypic analysis of reassortants of high growth and low growth strains of influenza B virus. Vaccine 2003, 21(25-26):3867-3874.
7. Podchernyaeva R.Y., Shchipanova M.V., Elkin V.S., Melnichenko E.I. Preparation of influenza B virus recombinant strains. Acta Virol 1987, 31(6):475-480.
8. Hoffmann E., Mahmood K., Yang C.F., Webster R.G., Greenberg H.B., Kemble G. Rescue of influenza B virus from eight plasmids. Proc Natl Acad Sci U S A 2002, 99(17):11411-11416.
9. Robertson J.S., Nicolson C., Harvey R., Johnson R., Major D., Guilfoyle K., et al. The development of vaccine viruses against pandemic A(H1N1) influenza. Vaccine 2011, 29(9):1836-1843.
10. Baez M., Palese P., Kilbourne E.D. Gene composition of high-yielding influenza vaccine strains obtained by recombination. J Infect Dis 1980, 141(3):362-365.
11. Fulvini A.A., Ramanunninair M., Le J., Pokorny B.A., Arroyo J.M., Silverman J., et al. Gene constellation of influenza A virus reassortants with high growth phenotype prepared as seed candidates for vaccine production. PLoS ONE 2011, 6(6):e20823. 10.1371/journal.pone.0020823.
12. Gallagher M., Bucher D.J., Dourmashkin R., Davis J.F., Rosenn G., Kilbourne E.D. Isolation of immunogenic neuraminidases of human influenza viruses by a combination of genetic and biochemical procedures. J Clin Microbiol 1984, 20(1):89-93.
13. Bucher D.J. Purification of neuraminidase from influenza viruses by affinity chromatography. Biochim Biophys Acta 1977, 482(2):393-399.
14. Hierholzer J.C., Suggs M.T., Hall E.C. Standardized viral hemagglutination and hemagglutination-inhibition tests. II. Description and statistical evaluation. Appl Microbiol 1969, 18(5):824-833.
15. World Health Organization Department of Communicable Disease Surveillance and Response WHO Manual on Animal Influenza Diagnosis and Surveillance. WHO/CDS/CSR/NCS/2002 5, rev 1 Geneva 2002, 32-33. World Health Organization, Switzerland.
16. Klimov A.I., Egorov A.Y., Gushchina M.I., Medvedeva T.E., Gamble W.C., Rudenko L.G., et al. Genetic stability of cold-adapted A/Leningrad/134/47/57 (H2N2) influenza virus: sequence analysis of live cold-adapted reassortant vaccine strains before and after replication in children. J Gen Virol 1995, 76(Pt 6):1521-1525.
17. Zhang W.D., Evans D.H. Detection and identification of human influenza viruses by the polymerase chain reaction. J Virol Methods 1991, 33(1-2):165-189.
18. Brett I., Werber J., Kilbourne E.D. Rapid confirmation by RFLP of transfer to vaccine candidate reassortment viruses of the principal 'high yield' gene of influenza A viruses. J Virol Methods 2002, 100(1-2):133-140.
19. Lugovtsev V.Y., Vodeiko G.M., Strupczewski C.M., Levandowski R.A. Simple and rapid strategy for genetic characterization of influenza B virus reassortants. J Virol Methods 2005, 124(1-2):203-210.
20. Stoeckle M.Y., Shaw M.W., Choppin P.W. Segment-specific and common nucleotide sequences in the noncoding regions of influenza B virus genome RNAs. Proc Natl Acad Sci U S A 1987, 84(9):2703-2707.
21. Francis T., Salk J.E., Quilligan J.J. Experience with vaccination against influenza in the spring of 1947: a preliminary report. Am J Public Health Nations Health 1947, 37(8):1013-1016.
22. Orff E.J. Influenza Type B M1 (Matrix) Protein: Intracellular Localization in Infected Cells and Association with High Yield Reassortment 1999, [PhD Thesis], New York Medical College.
23. Talon J., Horvath C.M., Polley R., Basler C.F., Muster T., Palese P., et al. Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J Virol 2000, 74(17):7989-7996.
24. Dauber B., Heins G., Wolff T. The influenza B virus nonstructural NS1 protein is essential for efficient viral growth and antagonizes beta interferon induction. J Virol 2004, 781865-781872.